SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals informs about outcome of board meeting

09 Feb 2022 Evaluate

In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bharat Parenterals has informed that that the Board of Directors of the Company in its meeting held on 09th February, 2022 has considered and approved the Unaudited Financial Results for the Quarter ended 31st December, 2021 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. In this respect, the company enclosed: Unaudited Financial Results for the Quarter ended 31st December, 2021 and Limited Review Report on the said Financial Results. The meeting of Board of Directors commenced at 01.30 pm and concluded at 02:00 pm.

The above information is a part of company’s filings submitted to BSE.



Bharat Parenterals Share Price

1208.00 -20.20 (-1.64%)
24-Apr-2026 15:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.50
Dr. Reddys Lab 1312.40
Cipla 1295.00
Zydus Lifesciences 930.00
Lupin 2285.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×